SPIROMETRY VERSUS AIRWAVE OSCILLOMETRY FOR ASSESSMENT OF MEPOLIZUMAB EFFICACY IN SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Yang, J. F. [1 ]
Pavord, I. D. [2 ]
Heaney, L. G. [3 ]
Brightling, C. E. [4 ]
Borg, K. [2 ]
Busby, J. [3 ]
Grandison, T. [5 ]
Smith, S. J. [5 ]
Lee, W. N. [5 ]
Shepherd, M. [1 ]
Chaudhuri, R. [1 ]
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Univ Oxford, Oxford, England
[3] Queen, Belfast, Antrim, North Ireland
[4] Univ Leicester, Leicester, Leics, England
[5] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.247
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P102
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 50 条
  • [21] Clinical usefulness of mepolizumab in severe eosinophilic asthma
    Menzella, Francesco
    Lusuardi, Mirco
    Montanari, Gloria
    Galeone, Carla
    Facciolongo, Nicola
    Zucchi, Luigi
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 907 - 916
  • [22] Bronchodilator response for oscillometry in severe eosinophilic asthma
    Chan, R.
    Kuo, C. R. W.
    Lipworth, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [23] Use of Mepolizumab in the Treatment of Severe Eosinophilic Asthma
    Strauss, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Mepolizumab, quality of life, and severe eosinophilic asthma
    Pavord, Ian D.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (05): : 362 - 363
  • [25] Mepolizumab for eosinophilic severe asthma: recent studies
    Robinson, Douglas S.
    Kariyawasam, Harsha H.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 909 - 914
  • [26] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [27] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
  • [28] Poorly Controlled Eosinophilic Asthma: Relationships of Airwave Oscillometry Resistance With CT Airway Measurements
    McIntosh, M.
    Kooner, H. K.
    Eddy, R. L.
    Licskai, C.
    Yamashita, C.
    Parraga, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma
    Russell, Richard
    Brightling, Christopher
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 607 - 617
  • [30] Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma
    Albers, Frank C.
    Lugogo, Njira
    Gilson, Martyn J.
    Price, Robert
    Yancey, StevenW.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB14 - AB14
12345